Rifaximin PCD Pharma Franchise Company
Cafoli Lifecare is a WHO-GMP certified Rifaximin PCD pharma franchise company offering a portfolio of 7 Rifaximin formulations across tablets and syrup. Every batch is manufactured at DCGI-approved facilities and supplied to franchise partners with district-level monopoly rights, ready-to-use promotional inputs and dependable stock availability.
What is Rifaximin?
Rifaximin is a non-absorbed, gut-selective antibiotic derived from rifamycin. It inhibits bacterial DNA-dependent RNA polymerase but stays almost entirely within the gastrointestinal lumen, giving a broad antibacterial effect in the gut with minimal systemic exposure. The compound record can be reviewed on PubChem.
Therapeutic Applications
Travellers diarrhoea, hepatic encephalopathy (for reduction of recurrence), irritable bowel syndrome with diarrhoea, and small intestinal bacterial overgrowth. It is also used in some hepatology protocols alongside lactulose.
Prescribed by: Gastroenterologists and hepatologists are the leading prescribers of Rifaximin, followed by general physicians managing infective diarrhoea and IBS.
Why Rifaximin is a High-Potential Molecule for Distributors
Rifaximin has an unusual commercial profile for an antibiotic: because it is barely absorbed, it is prescribed in long, repeating courses for hepatic encephalopathy and IBS-D rather than as a short one-week antibiotic course. That turns it into a chronic, refill-driven line inside a gastro portfolio. Liver disease and IBS are both under-served and rising in India, and prescriptions concentrate with gastroenterologists and hepatologists, so a distributor who builds relationships with a handful of specialists can generate disproportionate volume from a small prescriber base.
Why Choose Cafoli Lifecare
Cafoli Lifecare offers its Rifaximin franchise partners genuine monopoly rights for their allotted district or territory, products manufactured in WHO-GMP certified, DCGI-approved units, and complete promotional support — visual aids, MR bags, sample packs, product cards and doctor gifting. With 1000+ channel partners across India, on-time dispatch and transparent net rates, we make it straightforward to build a profitable Rifaximin business in your region.
References
- PubChem – Rifaximin compound record, US National Library of Medicine
- PubMed – clinical literature on Rifaximin, NCBI
Our formulations of Rifaximin find application in many critical therapeutic areas. Its therapeutic spectrum includes, but is not limited to: